These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11728520)

  • 21. Quantitative and qualitative changes in serum luteinizing hormone after injectable testosterone undecanoate treatment in hypogonadal men.
    Gu YQ; Ge ZY; Zhang GY; Bremner WJ
    Asian J Androl; 2000 Mar; 2(1):65-71. PubMed ID: 11228940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False negative results in testosterone doping in forensic cases: Sensitivity of the urinary detection criteria T/E and T/LH.
    Lood Y; Aardal E; Gustavsson S; Prasolov I; Josefsson M; Ahlner J
    Drug Test Anal; 2021 Oct; 13(10):1735-1742. PubMed ID: 34228890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis.
    van de Kerkhof DH; de Boer D; Thijssen JH; Maes RA
    J Anal Toxicol; 2000 Mar; 24(2):102-15. PubMed ID: 10732948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of Urinary and Serum Steroid Metabolites in Response to Testosterone Administration in Healthy Women.
    Elings Knutsson J; Andersson A; Baekken LV; Pohanka A; Ekström L; Hirschberg AL
    J Clin Endocrinol Metab; 2021 Mar; 106(3):697-707. PubMed ID: 33274381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone.
    Perry PJ; MacIndoe JH; Yates WR; Scott SD; Holman TL
    Clin Chem; 1997 May; 43(5):731-5. PubMed ID: 9166223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
    Qoubaitary A; Meriggiola C; Ng CM; Lumbreras L; Cerpolini S; Pelusi G; Christensen PD; Hull L; Swerdloff RS; Wang C
    J Androl; 2006; 27(6):853-67. PubMed ID: 16837736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
    Mazzarino M; Braganò MC; de la Torre X; Molaioni F; Botrè F
    Steroids; 2011 Nov; 76(12):1400-6. PubMed ID: 21745489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
    Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
    Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal and gonadal contributions to urinary excretion and plasma concentration of epitestosterone in men--effect of adrenal stimulation and implications for detection of testosterone abuse.
    Kicman AT; Coutts SB; Cowan DA; Handelsman DJ; Howe CJ; Burring S; Wu FC
    Clin Endocrinol (Oxf); 1999 May; 50(5):661-8. PubMed ID: 10468933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases.
    Garle M; Ocka R; Palonek E; Björkhem I
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):55-9. PubMed ID: 9001952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary analysis of four testosterone metabolites and pregnanediol by gas chromatography-combustion-isotope ratio mass spectrometry after oral administrations of testosterone.
    Maître A; Saudan C; Mangin P; Saugy M
    J Anal Toxicol; 2004 Sep; 28(6):426-31. PubMed ID: 15516291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transdermal administration of testosterone gel on the urinary steroid profile in hypogonadal men: Implications in antidoping analysis.
    Iannone M; Palermo A; de la Torre X; Romanelli F; Sansone A; Sansone M; Lenzi A; Botrè F
    Steroids; 2019 Dec; 152():108491. PubMed ID: 31499075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 alpha-hydroxyprogesterone.
    Carlström K; Palonek E; Garle M; Oftebro H; Stanghelle J; Björkhem I
    Clin Chem; 1992 Sep; 38(9):1779-84. PubMed ID: 1526014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and hormonal effects of testosterone undecanoate (TU) in male sexual impotence.
    Klepsch I; Măicănescu-Georgescu M; Marinescu L
    Endocrinologie; 1982; 20(4):289-93. PubMed ID: 6818673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfate metabolites improve retrospectivity after oral testosterone administration.
    Esquivel A; Alechaga É; Monfort N; Ventura R
    Drug Test Anal; 2019 Mar; 11(3):392-402. PubMed ID: 30362276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport.
    Dehennin L; Matsumoto AM
    J Steroid Biochem Mol Biol; 1993 Feb; 44(2):179-89. PubMed ID: 8439522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone.
    Lehtihet M; Andersson A; Börjesson A; Schulze J; Rane A; Ericsson M; Ekström L
    Drug Test Anal; 2018 Apr; 10(4):723-730. PubMed ID: 28901724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
    Savkovic S; Lim S; Jayadev V; Conway A; Turner L; Curtis D; Goebel C; Handelsman DJ
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2277-2283. PubMed ID: 29584875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.
    Sottas PE; Saudan C; Schweizer C; Baume N; Mangin P; Saugy M
    Forensic Sci Int; 2008 Jan; 174(2-3):166-72. PubMed ID: 17485185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary marker of oral pregnenolone administration.
    Saudan C; Desmarchelier A; Sottas PE; Mangin P; Saugy M
    Steroids; 2005 Mar; 70(3):179-83. PubMed ID: 15763596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.